查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587154

临床试验患者招募服务市场：按治疗领域、阶段和年龄组别划分 - 全球预测 2025-2030

Clinical Trial Patient Recruitment Services Market by Therapeutic Areas (Anti-Infective, Cardiovascular, Central Nervous System), Phase (Phase I, Phase II, Phase Ill), Age Group - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年临床试验患者招募服务市值为11.6亿美元，预计到2024年将达到12.7亿美元，复合年增长率为9.63%，到2030年将达到22.2亿美元。

临床试验患者招募服务的研究范围包括确定、参与和招募合适受试者进行临床试验的策略和工作，这是製药和医学研究领域的重要组成部分。日益复杂的试验设计、严格的监管要求以及需要多样化的参与者池以确保试验结果的广泛适用性都需要这些服务。典型应用包括病患人口统计、推广宣传活动、预筛检和后勤规划。最终用途领域主要是製药公司、委外研发机构(CRO) 和学术机构。该市场是由全球临床试验数量不断增加、个人化医疗需求不断增长以及数位健康技术的采用等因素所推动的。此外，COVID-19 大流行加速了远端和分散临床试验的创新，为提供患者招募技术解决方案（例如人工智慧主导的分析和虚拟登记工具）的公司创造了机会。然而，市场成长受到严格的资料隐私法、营运成本和参与者保留问题等挑战的阻碍。学术研究和小型製药公司的财务限制也是一个主要障碍。业务发展的创新领域包括开发机器学习演算法来识别和预测参与者的可用性以及使用社交媒体平台建立病人参与框架。与医疗保健提供者合作，更有效地整合患者资料，可以进一步了解患者的可用性和适用性。这个市场竞争激烈，因此您应该专注于与潜在的临床试验参与者和相关人员建立信任和透明度。利用技术优化成本、简化招募和加强沟通的公司将获得竞争优势。建议包括投资客製化数位平台以完善患者定位技术，并与高科技公司和医疗保健网络建立策略伙伴关係，以提高招募效率并扩大候选人库。

主要市场统计
基准年[2023] 11.6亿美元
预测年份 [2024] 12.7亿美元
预测年份 [2030] 22.2亿美元
复合年增长率（%） 9.63%

市场动态：针对快速发展的临床试验患者招募服务市场揭示的关键市场洞察

供需的动态交互作用正在改变临床试验患者招募服务市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 全球临床试验数量增加
    • 临床试验组织快速采用病患招募服务
    • 政府对病患参与计画的支持
  • 市场限制因素
    • 对公关服务高成本的担忧
  • 市场机会
    • 製药和生物技术领域的持续研发活动
    • 共同努力促进临床试验患者招募服务的成长
  • 市场挑战
    • 患者缺乏对临床试验的认识

波特五力：驾驭临床试验病患招募服务市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解临床试验病患招募服务市场的外部影响

外部宏观环境因素在塑造临床试验患者招募服务市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解临床试验病患招募服务市场的竞争状况

临床试验患者招募服务市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV 定位矩阵临床试验病患招募服务市场供应商的绩效评估

FPNV 定位矩阵是评估临床试验病患招募服务市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划临床试验病患招募服务市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对临床试验患者招募服务市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地的临床试验不断增加
      • 临床试验机构快速引进病患招募服务
      • 政府对病患参与计画的支持
    • 抑制因素
      • 对公关服务成本高的担忧
    • 机会
      • 製药和生物技术领域的持续研发活动
      • 共同努力加速临床试验患者招募服务的成长
    • 任务
      • 患者对临床试验缺乏认识
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依治疗领域分類的临床试验病患招募服务市场

  • 抗感染
  • 心血管
  • 中枢神经系统
  • 内分泌
  • 肿瘤学
  • 疼痛和麻醉
  • 呼吸系统疾病

第七章临床试验病患招募服务市场分阶段

  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第八章临床试验病患招募服务市场：依年龄组

  • 成人用
  • 孩子

第九章美洲临床试验病患招募服务市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太临床试验病患招募服务市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲临床试验病患招募服务市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Antidote Technologies, Inc.
  • AutoCruitment LLC by QHP Capital
  • BBK Worldwide, LLC
  • Biorasi, LLC
  • Clara Health by M&B Sciences Inc.
  • Clariness GmbH
  • Clinical Site Services（CCSi）
  • Conduent, Inc.
  • Elligo Health Research
  • IQVIA Inc. by Q2 Metrics
  • Matthews Media Group Inc.
  • MESM Ltd by VWR
  • PatientEvolution
  • PPD Inc. by Thermo Fisher Scientific
  • Science 37, Inc. by LifeSci Acquisition II Corp.
  • Syneos Health
  • Trialbee AB
  • Trialfacts
  • Veristat
  • Worldwide Clinical Trials
Product Code: MRR-8C74ADFBFBFA

The Clinical Trial Patient Recruitment Services Market was valued at USD 1.16 billion in 2023, expected to reach USD 1.27 billion in 2024, and is projected to grow at a CAGR of 9.63%, to USD 2.22 billion by 2030.

The scope of Clinical Trial Patient Recruitment Services encompasses the strategies and efforts to identify, engage, and enroll suitable participants for clinical trials, a critical component of the pharmaceutical and medical research sectors. These services are necessary due to increasing complexities in trial designs, stringent regulatory requirements, and the need for diverse participant pools to ensure broad applicability of trial results. Key applications include patient demographics identification, outreach campaigns, pre-screening, and logistical planning. End-use sectors primarily involve pharmaceutical companies, contract research organizations (CROs), and academic institutions. The market is driven by factors such as the global rise in clinical trials, growing demand for personalized medicine, and the adoption of digital health technologies. Moreover, the COVID-19 pandemic accelerated innovations in remote and decentralized trials, creating opportunities for companies offering technological solutions in patient recruitment, such as AI-driven analytics and virtual enrollment tools. However, market growth is impeded by challenges like stringent data privacy laws, operational costs, and participant retention issues. Financial constraints in academic research and smaller pharmaceutical firms also pose significant barriers. Innovative areas for business advancement include the development of machine learning algorithms for identification and prediction of participant availability and establishing patient engagement frameworks using social media platforms. Collaboration with healthcare providers to integrate patient data more effectively offers additional insights into patient availability and suitability. The highly competitive nature of this market necessitates a focus on building trust and transparency with potential trial participants and stakeholders. Companies that leverage technology to optimize costs, streamline recruitment, and enhance communication stand to gain a competitive edge. Recommendations include investing in customized digital platforms to refine patient targeting techniques and forming strategic partnerships with tech companies and medical networks to enhance recruitment efficacy and expand the candidate pool.

KEY MARKET STATISTICS
Base Year [2023] USD 1.16 billion
Estimated Year [2024] USD 1.27 billion
Forecast Year [2030] USD 2.22 billion
CAGR (%) 9.63%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Trial Patient Recruitment Services Market

The Clinical Trial Patient Recruitment Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of clinical trials all over the globe
    • Rapid adoption of patient recruitment sevices by clinical trial organizations
    • Government support for patient engagement programs
  • Market Restraints
    • Concern associated with substantial cost of the PR services
  • Market Opportunities
    • Ongoing research and development activities in pharmaceuticals and biotechnology sector
    • Collaborative efforts to enhance the growth of the clinical trials patient recruitment services
  • Market Challenges
    • Lack of awareness about clinical trials in patients

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Trial Patient Recruitment Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Trial Patient Recruitment Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Trial Patient Recruitment Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Trial Patient Recruitment Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Trial Patient Recruitment Services Market

A detailed market share analysis in the Clinical Trial Patient Recruitment Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Trial Patient Recruitment Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Trial Patient Recruitment Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Clinical Trial Patient Recruitment Services Market

A strategic analysis of the Clinical Trial Patient Recruitment Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Patient Recruitment Services Market, highlighting leading vendors and their innovative profiles. These include Antidote Technologies, Inc., AutoCruitment LLC by QHP Capital, BBK Worldwide, LLC, Biorasi, LLC, Clara Health by M&B Sciences Inc., Clariness GmbH, Clinical Site Services (CCSi), Conduent, Inc., Elligo Health Research, IQVIA Inc. by Q2 Metrics, Matthews Media Group Inc., MESM Ltd by VWR, PatientEvolution, PPD Inc. by Thermo Fisher Scientific, Science 37, Inc. by LifeSci Acquisition II Corp., Syneos Health, Trialbee AB, Trialfacts, Veristat, and Worldwide Clinical Trials.

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Patient Recruitment Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Therapeutic Areas, market is studied across Anti-Infective, Cardiovascular, Central Nervous System, Endocrine, Oncology, Pain & Anesthesia, and Respiratory Diseases.
  • Based on Phase, market is studied across Phase I, Phase II, Phase Ill, and Phase IV.
  • Based on Age Group, market is studied across Adult and Child.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of clinical trials all over the globe
      • 5.1.1.2. Rapid adoption of patient recruitment sevices by clinical trial organizations
      • 5.1.1.3. Government support for patient engagement programs
    • 5.1.2. Restraints
      • 5.1.2.1. Concern associated with substantial cost of the PR services
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development activities in pharmaceuticals and biotechnology sector
      • 5.1.3.2. Collaborative efforts to enhance the growth of the clinical trials patient recruitment services
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness about clinical trials in patients
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clinical Trial Patient Recruitment Services Market, by Therapeutic Areas

  • 6.1. Introduction
  • 6.2. Anti-Infective
  • 6.3. Cardiovascular
  • 6.4. Central Nervous System
  • 6.5. Endocrine
  • 6.6. Oncology
  • 6.7. Pain & Anesthesia
  • 6.8. Respiratory Diseases

7. Clinical Trial Patient Recruitment Services Market, by Phase

  • 7.1. Introduction
  • 7.2. Phase I
  • 7.3. Phase II
  • 7.4. Phase Ill
  • 7.5. Phase IV

8. Clinical Trial Patient Recruitment Services Market, by Age Group

  • 8.1. Introduction
  • 8.2. Adult
  • 8.3. Child

9. Americas Clinical Trial Patient Recruitment Services Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Clinical Trial Patient Recruitment Services Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Clinical Trial Patient Recruitment Services Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Antidote Technologies, Inc.
  • 2. AutoCruitment LLC by QHP Capital
  • 3. BBK Worldwide, LLC
  • 4. Biorasi, LLC
  • 5. Clara Health by M&B Sciences Inc.
  • 6. Clariness GmbH
  • 7. Clinical Site Services (CCSi)
  • 8. Conduent, Inc.
  • 9. Elligo Health Research
  • 10. IQVIA Inc. by Q2 Metrics
  • 11. Matthews Media Group Inc.
  • 12. MESM Ltd by VWR
  • 13. PatientEvolution
  • 14. PPD Inc. by Thermo Fisher Scientific
  • 15. Science 37, Inc. by LifeSci Acquisition II Corp.
  • 16. Syneos Health
  • 17. Trialbee AB
  • 18. Trialfacts
  • 19. Veristat
  • 20. Worldwide Clinical Trials

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY ANTI-INFECTIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY ENDOCRINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PAIN & ANESTHESIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE ILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY CHILD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 150. CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. CLINICAL TRIAL PATIENT RECRUITMENT SERVICES MARKET, FPNV POSITIONING MATRIX, 2023